Pricing Log in Create free account

Medline Inc. (MDLN) vs Repligen Corporation (RGEN)

Medline Inc. and Repligen Corporation are both Medical Instruments & Supplies companies. Medline Inc. is the larger, with a market value of $48.1B against $11.7B — 4.1× the size. Repligen Corporation has the higher net margin (5.29% vs 2.37%) and the lower return on invested capital (2.18% vs 19.9%). Across the 16 metrics below, Medline Inc. leads on 9 and Repligen Corporation on 7.

Valuation

Metric MDLN RGEN Medical Instruments & Supplies median
P/E — 233.60 33.75
P/S 1.04 12.59 2.52
P/B 1.62 4.68 2.48
Price to free cash flow 13.38 161.81 25.19
EV/EBITDA 4.05 60.20 14.62
EV/Sales 1.37 12.35 2.88
Earnings yield — 0.43% (2.67%)
Free cash flow yield 7.48% 0.62% 0.09%

Profitability

Metric MDLN RGEN Medical Instruments & Supplies median
Gross margin 46.27% 53.52% 54.29%
Operating margin 31.12% 8.23% 1.07%
Net margin 2.37% 5.29% (1.61%)
Free cash flow margin 7.75% 14.06% 1.08%
Return on equity 0.00% 1.99% (1.32%)
Return on assets 3.58% 1.42% 0.00%
Return on invested capital 19.94% 2.18% 0.00%

Growth

Metric MDLN RGEN Medical Instruments & Supplies median
Revenue growth (TTM) — 16.49% 8.85%
EPS growth (last fiscal year) — 286.96% 8.65%
Revenue growth, 5-year CAGR — 15.05% 9.17%
Net income growth, 5-year CAGR — (3.99%) 0.00%

Health

Metric MDLN RGEN Medical Instruments & Supplies median
Debt to equity 0.66 0.26 0.10
Current ratio 4.33 9.05 2.48
Net debt to EBITDA 3.24 (1.50) 0.89

Dividend

Metric MDLN RGEN Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric MDLN RGEN Medical Instruments & Supplies median
Market cap 48.08b 11.69b 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack